TYGACIL Side Effects

6867508-0 | Chills, Dizziness, Feeling Cold, Feeling Hot, Flushing, Hypoaesthesia, Malaise, Nausea, Paralysis
on Jul 13, 2010 Female patient from UNITED STATES , weighting 119.1 lb, was diagnosed with lyme disease, multiple sclerosis (What is multiple sclerosis?), anxiety (What is anxiety?), depression (What is depression?) and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: chills, dizziness (What is dizziness?), feeling cold, feeling hot, flushing, hypoaesthesia, malaise, nausea (What is nausea?), paralysis (What is paralysis?). Tygacil dosage: . During the same period patient was treated with XANAX (1-2 As Needed Per Week) (View Xanax Review and Xanax Label ), COPAXONE (View Copaxone Review and Copaxone Label ), PAXIL (View Paxil Review and Paxil Label ).

6866309-7 | Cholestasis, Sepsis
Patient was taking Tygacil (View Usage). Patient had the following side effects: cholestasis, sepsis (What is sepsis?) on Jul 16, 2010 from MEXICO Additional patient health information: Male patient , 58 years of age, . Tygacil dosage: .

6859912-1 | Abdominal Infection, Morganella Infection, Superinfection
Adverse event was reported on Jul 08, 2010 by a Male patient taking Tygacil (View Usage) (Dosage: 100 Mg Loading Dose, Then 50 Mg Q 12h) was diagnosed with acinetobacter infection, abdominal abscess, post procedural infection and. Location: SPAIN , 72 years of age, After Tygacil was administered, patient had the following side effects: abdominal infection, morganella infection, superinfection. Patient was hospitalized.

6859911-X | Abdominal Abscess, Pseudomonas Infection, Superinfection
on Jul 08, 2010 Female patient from SPAIN , 56 years of age, was diagnosed with acinetobacter infection, abdominal abscess and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal abscess, pseudomonas infection, superinfection. Tygacil dosage: 100 Mg Loading Dose, Then 50 Mg Q12h. During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ). Patient was hospitalized.


6839650-1 | Pathogen Resistance
on Jul 12, 2010 Male patient from FRANCE , weighting 189.6 lb, was diagnosed with escherichia sepsis, peritoneal infection, pleural infection bacterial, prophylaxis against transplant rejection and was treated with Tygacil (View Usage). Patient had the following side effects: pathogen resistance. Tygacil dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), SOLUPRED (60 Mg Total Daily) (View Solupred Review and Solupred Label ). Patient was hospitalized.

6819350-4 | Coagulation Time Prolonged, Haemorrhage
Patient was taking Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: coagulation time prolonged, haemorrhage on Jun 28, 2010 from COLOMBIA Additional patient health information: Male patient , 62 years of age, was diagnosed with peritonitis, malaise, gastritis, coagulopathy and. Tygacil dosage: . During the same period patient was treated with PLASIL (View Plasil Review and Plasil Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FRAGMIN (5000 Ui/daily) (View Fragmin Review and Fragmin Label ).

6809381-2 | Septic Shock, Staphylococcal Infection
Adverse event was reported on Jun 22, 2010 by a Female patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), intracranial pressure increased and. Location: SPAIN , 18 years of age, Patient experienced the following unwanted or unexpected effects: septic shock, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with CLOXACILLIN (View Cloxacillin Review and Cloxacillin Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), COLISTIN (View Colistin Review and Colistin Label ).

6809380-0 | Blood Alkaline Phosphatase Increased, Cholestasis, Gamma-glutamyltransferase Increased, Transaminases Increased
on Jun 22, 2010 Female patient from SPAIN , 74 years of age, was diagnosed with diabetic foot infection and was treated with Tygacil (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, transaminases increased. Tygacil dosage: . During the same period patient was treated with CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), MAGNESIUM LACTATE (View Magnesium Lactate Review and Magnesium Lactate Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6801817-6 | International Normalised Ratio Increased, Pulmonary Embolism
on Jun 18, 2010 Male patient from UNITED STATES , 84 years of age, weighting 130.1 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?), atrial flutter and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: international normalised ratio increased, pulmonary embolism (What is pulmonary embolism?). Tygacil dosage: 100mg Loading Dose Then 50mg Every 12 Hours. During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

6780148-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cholestasis, Gamma-glutamyltransferase Increased, Transaminases Increased
Patient was taking Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, gamma-glutamyltransferase increased, transaminases increased on Jun 10, 2010 from SPAIN Additional patient health information: Female patient , 74 years of age, was diagnosed with diabetic foot infection and. Tygacil dosage: . During the same period patient was treated with CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), MAGNESIUM LACTATE (View Magnesium Lactate Review and Magnesium Lactate Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6751188-9 | Septic Shock
Adverse event was reported on May 28, 2010 by a Female patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with peritonitis and. Location: FRANCE , 65 years of age, weighting 136.7 lb, Patient had the following side effects: septic shock.

6744667-1 | Blood Alkaline Phosphatase Increased, Cholestasis, Gamma-glutamyltransferase Increased, Transaminases Increased
on May 27, 2010 Female patient from SPAIN , 74 years of age, was diagnosed with diabetic foot infection and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, transaminases increased. Tygacil dosage: . Patient was hospitalized.

6742509-1 | Hepatic Failure
on May 26, 2010 Female patient from GERMANY , 49 years of age, was diagnosed with peritonitis and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure. Tygacil dosage: .

6742114-7 | Diarrhoea, Lethargy, Nausea, Weight Decreased
Patient was taking Tygacil (View Usage). Patient had the following side effects: diarrhoea, lethargy, nausea (What is nausea?), weight decreased on May 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 129.1 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Tygacil dosage: 50 Mg Vial Daily. During the same period patient was treated with EXTRA STRENGTH TYLENOL PM (View Extra Strength Tylenol Pm Review and Extra Strength Tylenol Pm Label ).

6736624-6 | Multi-organ Failure, Septic Shock
Adverse event was reported on May 19, 2010 by a Male patient taking Tygacil (View Usage) (Dosage: 100 Mg Total Daily) was diagnosed with cholangitis, enterococcal bacteraemia, shock, candidiasis and. Location: FRANCE , weighting 195.1 lb, After Tygacil was administered, patient had the following side effects: multi-organ failure, septic shock. During the same period patient was treated with ZESTORETIC (View Zestoretic Review and Zestoretic Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), VANCOMYCIN (2 G Total Daily) (View Vancomycin Review and Vancomycin Label ), CANCIDAS (50 Mg Total Daily) (View Cancidas Review and Cancidas Label ).

6722686-9 | Septic Shock
on May 11, 2010 Female patient from FRANCE , 65 years of age, weighting 136.7 lb, was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: septic shock. Tygacil dosage: .

6718169-2 |
on May 06, 2010 Female patient from FRANCE , 65 years of age, was treated with Tygacil (View Usage). . Tygacil dosage: .

6710554-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cholelithiasis
Patient was taking Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholelithiasis on Apr 23, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 123.5 lb, was diagnosed with abdominal abscess, ascites, impaired gastric emptying, portal hypertension and. Tygacil dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), INSULIN (View Insulin Review and Insulin Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6708579-1 | Multi-organ Failure, Septic Shock
Adverse event was reported on May 03, 2010 by a Male patient taking Tygacil (View Usage) (Dosage: 100 Mg Total Daily) was diagnosed with cholangitis, enterococcal bacteraemia, shock, candidiasis and. Location: FRANCE , weighting 195.1 lb, Patient experienced the following unwanted or unexpected effects: multi-organ failure, septic shock. During the same period patient was treated with ZESTORETIC (View Zestoretic Review and Zestoretic Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), VANCOMYCIN (2 G Total Daily) (View Vancomycin Review and Vancomycin Label ), CANCIDAS (50 Mg Total Daily) (View Cancidas Review and Cancidas Label ).

6707009-3 | Cholestasis
on Apr 30, 2010 Male patient from UNITED STATES , 81 years of age, was diagnosed with clostridial infection and was treated with Tygacil (View Usage). Patient had the following side effects: cholestasis. Tygacil dosage: 50mg Q12h Iv. Patient was hospitalized.

6702709-3 | Cardiac Arrest, Epidermolysis, Rash Maculo-papular, Rash Pustular, Skin Hyperpigmentation, Skin Reaction
on Apr 26, 2010 Female patient from GREECE , 74 years of age, weighting 143.3 lb, was diagnosed with klebsiella bacteraemia and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), epidermolysis, rash maculo-papular, rash pustular, skin hyperpigmentation, skin reaction. Tygacil dosage: . During the same period patient was treated with NEXIUM (One Tablet Daily) (View Nexium Review and Nexium Label ), GLOPIR (View Glopir Review and Glopir Label ), PREZOLON (View Prezolon Review and Prezolon Label ), CAPOTEN (View Capoten Review and Capoten Label ), DILATREND (View Dilatrend Review and Dilatrend Label ), GARAMYCIN (View Garamycin Review and Garamycin Label ), CLEXANE (View Clexane Review and Clexane Label ). Patient was hospitalized.

6699201-1 | Multi-organ Failure, Septic Shock
Patient was taking Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, septic shock on Apr 23, 2010 from FRANCE Additional patient health information: Male patient , weighting 195.1 lb, was diagnosed with cholangitis, enterococcal bacteraemia, shock, candidiasis and. Tygacil dosage: 100 Mg Total Daily. During the same period patient was treated with ZESTORETIC (View Zestoretic Review and Zestoretic Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), VANCOMYCIN (2 G Total Daily) (View Vancomycin Review and Vancomycin Label ), CANCIDAS (50 Mg Total Daily) (View Cancidas Review and Cancidas Label ).

6690895-3 | Condition Aggravated, Dermatitis Allergic, Dyspnoea
Adverse event was reported on Apr 20, 2010 by a Male patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with diabetic foot infection, dermatitis allergic, peripheral arterial occlusive disease and. Location: GERMANY , weighting 158.7 lb, Patient had the following side effects: condition aggravated, dermatitis allergic, dyspnoea. During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), GLUCOCORTICOIDS (View Glucocorticoids Review and Glucocorticoids Label ), LASIX (View Lasix Review and Lasix Label ), PLAVIX (View Plavix Review and Plavix Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6688957-X | Blood Alkaline Phosphatase Increased, Cholestasis, Gamma-glutamyltransferase Increased, Transaminases Increased
on Apr 16, 2010 Female patient from SPAIN , 74 years of age, was diagnosed with diabetic foot infection and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, transaminases increased. Tygacil dosage: . Patient was hospitalized.

6687269-8 | Pathogen Resistance
on Apr 19, 2010 Male patient from FRANCE , weighting 189.6 lb, was diagnosed with escherichia sepsis, peritoneal infection, pleural infection bacterial, prophylaxis against transplant rejection and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: pathogen resistance. Tygacil dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), SOLUPRED (60 Mg Total Daily) (View Solupred Review and Solupred Label ). Patient was hospitalized.

6677979-0 | Pathogen Resistance
Patient was taking Tygacil (View Usage). Patient had the following side effects: pathogen resistance on Apr 08, 2010 from FRANCE Additional patient health information: Male patient , 46 years of age, weighting 189.6 lb, was diagnosed with escherichia sepsis, peritoneal infection, pleural infection bacterial, prophylaxis against transplant rejection and. Tygacil dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), SOLUPRED (60 Mg Total Daily) (View Solupred Review and Solupred Label ). Patient was hospitalized.

6667145-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cardio-respiratory Arrest, Hepatic Encephalopathy, Hepatic Infarction, Ischaemic Cardiomyopathy
Adverse event was reported on Mar 25, 2010 by a Female patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?) and. Location: UNITED STATES , 65 years of age, After Tygacil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cardio-respiratory arrest, hepatic encephalopathy, hepatic infarction, ischaemic cardiomyopathy. During the same period patient was treated with MYCAMINE (View Mycamine Review and Mycamine Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), ZOSYN (View Zosyn Review and Zosyn Label ), DORIPENEM (View Doripenem Review and Doripenem Label ), ZYVOX (View Zyvox Review and Zyvox Label ).

6659542-0 | Ascites
on Mar 26, 2010 Female patient from GERMANY , weighting 154.3 lb, was diagnosed with abdominal infection and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: ascites. Tygacil dosage: . During the same period patient was treated with CYCLOKAPRON (View Cyclokapron Review and Cyclokapron Label ), EBRANTIL (View Ebrantil Review and Ebrantil Label ), AMBISOME (View Ambisome Review and Ambisome Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ACTRAPID HUMAN (View Actrapid Human Review and Actrapid Human Label ), CERNEVIT 12 (View Cernevit-12 Review and Cernevit-12 Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ). Patient was hospitalized.

6645623-4 | Multi-organ Failure, Sepsis, Toxic Epidermal Necrolysis
on Mar 18, 2010 Male patient from GERMANY , weighting 165.3 lb, was diagnosed with abdominal infection and was treated with Tygacil (View Usage). Patient had the following side effects: multi-organ failure, sepsis (What is sepsis?), toxic epidermal necrolysis. Tygacil dosage: . During the same period patient was treated with ARTERENOL (View Arterenol Review and Arterenol Label ), DOBUTAMINE (View Dobutamine Review and Dobutamine Label ), DIGIMERCK (View Digimerck Review and Digimerck Label ), POTASSIUM (View Potassium Review and Potassium Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), DORMICUM (View Dormicum Review and Dormicum Label ).

6641153-4 | Pseudomonas Infection
Patient was taking Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: pseudomonas infection on Mar 17, 2010 from GERMANY Additional patient health information: Male patient , 79 years of age, weighting 187.4 lb, was diagnosed with pneumonia (What is pneumonia?) and. Tygacil dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FORTUM (View Fortum Review and Fortum Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACTRAPID MC (View Actrapid Mc Review and Actrapid Mc Label ).

6631353-1 | Hepatic Enzyme Increased, Pancreatic Enzymes Increased
Adverse event was reported on Mar 10, 2010 by a Male patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with appendicitis perforated and. Location: GERMANY , 51 years of age, weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, pancreatic enzymes increased.

6628872-0 | Pseudomonas Infection
on Mar 01, 2010 Male patient from GERMANY , 79 years of age, weighting 187.4 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Tygacil (View Usage). Patient had the following side effects: pseudomonas infection. Tygacil dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FORTUM (View Fortum Review and Fortum Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACTRAPID MC (View Actrapid Mc Review and Actrapid Mc Label ).

6614218-0 | Hepatic Failure
on Mar 04, 2010 Female patient from GERMANY , 49 years of age, was diagnosed with peritonitis and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: hepatic failure. Tygacil dosage: .

6609409-9 | Adrenal Adenoma, Adrenal Haemorrhage, Arteriosclerosis, Bladder Disorder, Circulatory Collapse, Diverticulitis, Haemorrhagic Diathesis, Hepatic Failure, Lipoma
Patient was taking Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal adenoma, adrenal haemorrhage, arteriosclerosis, bladder disorder, circulatory collapse, diverticulitis, haemorrhagic diathesis, hepatic failure, lipoma on Feb 25, 2010 from GERMANY Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with abdominal infection and. Tygacil dosage: . During the same period patient was treated with ARTERENOL (View Arterenol Review and Arterenol Label ), DOBUTAMINE (View Dobutamine Review and Dobutamine Label ), DIGIMERCK (View Digimerck Review and Digimerck Label ), POTASSIUM (View Potassium Review and Potassium Label ), TOREM (View Torem Review and Torem Label ), DORMICUM (View Dormicum Review and Dormicum Label ), SUFENTA (View Sufenta Review and Sufenta Label ).

6545449-6 | Stevens-johnson Syndrome
Adverse event was reported on Jan 18, 2010 by a Female patient taking Tygacil (View Usage) (Dosage: 100 Mg (once)) . Location: COSTA RICA , 54 years of age, Patient had the following side effects: stevens-johnson syndrome.

6484924-X | Anuria, Circulatory Collapse, Hepatic Function Abnormal, Sepsis
on Dec 07, 2009 Female patient from GERMANY , weighting 224.9 lb, was diagnosed with systemic inflammatory response syndrome, infection (What is infection?) and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: anuria, circulatory collapse, hepatic function abnormal, sepsis (What is sepsis?). Tygacil dosage: . During the same period patient was treated with SILDENAFIL (View Sildenafil Review and Sildenafil Label ), NOREPINEPHRINE BITARTRATE (View Norepinephrine Bitartrate Review and Norepinephrine Bitartrate Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LIOTHYRONINE SODIUM (View Liothyronine Sodium Review and Liothyronine Sodium Label ), TAZOBACTAM (View Tazobactam Review and Tazobactam Label ).

6470099-X | Myopathy
on Nov 25, 2009 Male patient from SOUTH AFRICA , 45 years of age, was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: myopathy. Tygacil dosage: 100mg Loading Dose Then 50mg Bid. Patient was hospitalized.

6466367-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Patient was taking Tygacil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased on Dec 01, 2009 from UNITED STATES Additional patient health information: Female patient , 93 years of age, weighting 109.0 lb, was diagnosed with klebsiella infection and. Tygacil dosage: 100mg X1, Then 50mg Q12h Q12h Iv. Patient was hospitalized.

6464332-8 | Multi-organ Failure, Pleural Effusion, Sepsis, White Blood Cell Count Increased
Adverse event was reported on Nov 27, 2009 by a Male patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with peritonitis, diverticular perforation and. Location: ITALY , 44 years of age, After Tygacil was administered, patient had the following side effects: multi-organ failure, pleural effusion, sepsis (What is sepsis?), white blood cell count increased. During the same period patient was treated with MERREM (Not Provided) (View Merrem Review and Merrem Label ), METRONIDAZOLE (Not Provided) (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6451234-6 | Cardiac Arrest, Platelet Count Decreased
on Nov 19, 2009 Male patient from GREECE , 83 years of age, was diagnosed with gangrene and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), platelet count decreased. Tygacil dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), HEPARIN (View Heparin Review and Heparin Label ), CIPROXIN (View Ciproxin Review and Ciproxin Label ). Patient was hospitalized.

6442187-5 | Haemolysis
on Nov 13, 2009 Male patient from GREECE , 81 years of age, was diagnosed with febrile infection and was treated with Tygacil (View Usage). Patient had the following side effects: haemolysis. Tygacil dosage: 50 Mg Twice Daily. Patient was hospitalized.

6424024-8 | Pancreatitis
Patient was taking Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: pancreatitis on Oct 30, 2009 from UNITED STATES Additional patient health information: Male patient , 43 years of age, weighting 232.0 lb, was diagnosed with pelvic abscess and. Tygacil dosage: Tygacil 50 Mg Q12h Iv Drip. Patient was hospitalized.

6418920-5 | Cerebral Infarction, Convulsion, Muscular Weakness
Adverse event was reported on Oct 21, 2009 by a Male patient taking Tygacil (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?), duodenitis, anaemia, infection (What is infection?), thrombosis prophylaxis and. Location: UNITED STATES , weighting 161.8 lb, Patient experienced the following unwanted or unexpected effects: cerebral infarction, convulsion, muscular weakness. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DARBEPOETIN ALFA (60 Mcg Weekly) (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), HEPARIN (5000 Unit Every 12 Hr) (View Heparin Review and Heparin Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), RIVASTIGMINE TARTRATE (View Rivastigmine Tartrate Review and Rivastigmine Tartrate Label ).

6406827-9 | Decreased Appetite, Depression Suicidal, Nausea
on Oct 13, 2009 Male patient from ISRAEL , 50 years of age, was diagnosed with abscess (What is abscess?), mycobacterial infection, nausea (What is nausea?) and was treated with Tygacil (View Usage). Patient had the following side effects: decreased appetite, depression suicidal, nausea (What is nausea?). Tygacil dosage: . During the same period patient was treated with ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ).

6396678-6 | Acinetobacter Infection, Candidiasis, Clostridium Difficile Colitis, Sepsis, Stenotrophomonas Infection
on Oct 01, 2009 Female patient from ISRAEL , child 3 years of age, was diagnosed with sepsis (What is sepsis?), acinetobacter infection, candidiasis, stenotrophomonas infection and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: acinetobacter infection, candidiasis, clostridium difficile colitis, sepsis (What is sepsis?), stenotrophomonas infection. Tygacil dosage: Empiric Dose 16 Mg. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), AMIKACIN (Uknown) (View Amikacin Review and Amikacin Label ), COLIRACIN (View Coliracin Review and Coliracin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

6383435-X | Hepatic Failure, Renal Failure, Respiratory Failure
Patient was taking Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure, renal failure, respiratory failure on Sep 28, 2009 from GERMANY Additional patient health information: Female patient , weighting 114.6 lb, was diagnosed with aspergillosis and. Tygacil dosage: . During the same period patient was treated with VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), L THYROXIN (View L-thyroxin Review and L-thyroxin Label ), TAVANIC (View Tavanic Review and Tavanic Label ), RANITIC (View Ranitic Review and Ranitic Label ), HEPARIN (View Heparin Review and Heparin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6379722-1 | Nausea
Adverse event was reported on Sep 24, 2009 by a Male patient taking Tygacil (View Usage) (Dosage: 100mg Q24h Iv Drip) was diagnosed with diabetic foot infection and. Location: UNITED STATES , 37 years of age, weighting 155.0 lb, Patient had the following side effects: nausea (What is nausea?).

6361908-3 | Haemolysis
on Sep 17, 2009 Male patient from GREECE , 81 years of age, was diagnosed with febrile infection and was treated with Tygacil (View Usage). After Tygacil was administered, patient had the following side effects: haemolysis. Tygacil dosage: 50 Mg Twice Daily. Patient was hospitalized.

6358363-6 | Pancytopenia
on Sep 10, 2009 Male patient from SPAIN , 61 years of age, weighting 138.5 lb, was diagnosed with localised intraabdominal fluid collection and was treated with Tygacil (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Tygacil dosage: . During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), EMCONCOR (View Emconcor Review and Emconcor Label ), KONAKION (View Konakion Review and Konakion Label ), PANTECTA (View Pantecta Review and Pantecta Label ), TAVANIC (View Tavanic Review and Tavanic Label ), URSOBIL (View Ursobil Review and Ursobil Label ), ZOCOR (View Zocor Review and Zocor Label ).

6355869-0 | Hypoglycaemia
Patient was taking Tygacil (View Usage). Patient had the following side effects: hypoglycaemia on Sep 10, 2009 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 251.3 lb, was diagnosed with sepsis (What is sepsis?) and. Tygacil dosage: 100 Mg Single Dose Intravenous. Patient was hospitalized.